Does ALIROCUMAB Cause Peripheral swelling? 222 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 222 reports of Peripheral swelling have been filed in association with ALIROCUMAB (Praluent). This represents 1.0% of all adverse event reports for ALIROCUMAB.
222
Reports of Peripheral swelling with ALIROCUMAB
1.0%
of all ALIROCUMAB reports
1
Deaths
29
Hospitalizations
How Dangerous Is Peripheral swelling From ALIROCUMAB?
Of the 222 reports, 1 (0.5%) resulted in death, 29 (13.1%) required hospitalization.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 222 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which ALIROCUMAB Alternatives Have Lower Peripheral swelling Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN